TrialCNS drugs2020

Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.

Yves Dauvilliers et al.PubMed ↗Publisher ↗

No numbers read from the abstract.